TI
NUVB icon

Trexquant Investment’s Nuvation Bio NUVB Stock Holding History

Trexquant Investment’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$92.5K Sell
21,559
-165,328
-88% -$921K ﹤0.01% 1707
2025
Q4 		$1.67M Buy
+186,887
New +$1.16M 0.01% 1048
2022
Q2 		– Sell
-44,032
Closed -$232K – 1750
2022
Q1 		$232K Buy
44,032
+19,556
+80% +$110K 0.01% 1134
2021
Q4 		$208K Buy
+24,476
New +$225K 0.01% 1128
2021
Q3 		– Sell
-22,873
Closed -$213K – 1374
2021
Q2 		$213K Buy
+22,873
New +$261K 0.02% 884

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Trexquant Investment's NUVB Position: Q1 2026 in Review

Trexquant Investment reduced its Nuvation Bio (NUVB) stake by 88% in Q1 2026, selling an estimated $921K and leaving 21,559 shares worth $92.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1707.

Trexquant Investment first reported a position in NUVB in Q2 2021 and has held it in 5 quarters since. The position peaked at $1.67M in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.

  • Trexquant Investment held 21,559 shares of Nuvation Bio worth $92.5K as of Q1 2026.
  • Trexquant Investment sold 165,328 Nuvation Bio shares in Q1 2026, an estimated $921K.
  • Nuvation Bio made up ﹤0.01% of Trexquant Investment's portfolio in Q1 2026, its #1707 holding.
  • Trexquant Investment first reported a position in Nuvation Bio in Q2 2021 and has held it in 5 quarters since.
  • Trexquant Investment's Nuvation Bio position peaked at $1.67M in Q4 2025.
  • 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.

Based on Trexquant Investment's 13F filing for Q1 2026, filed 15 May 2026.